Biogen Inc. (BIIB)

Biogen Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	32,963	37,495	39,877	35,242	37,679	53,543
Market Cap Growth	-21.97%	-5.97%	13.15%	-6.47%	-29.63%	-11.69%
Enterprise Value	38,835	43,784	41,598	39,043	42,898	55,434
PE Ratio	28.26	32.29	13.09	22.65	9.42	9.09
PS Ratio	3.41	3.81	3.92	3.21	2.80	3.72
PB Ratio	2.17	2.53	2.98	3.23	3.52	4.01
P/FCF Ratio	25.66	30.34	23.13	10.48	10.04	8.35
P/OCF Ratio	20.04	24.23	28.81	9.68	8.91	7.56
EV/Sales Ratio	4.02	4.45	4.09	3.56	3.19	3.86
EV/EBITDA Ratio	20.96	24.44	9.63	14.32	7.58	7.17
EV/EBIT Ratio	29.36	33.77	11.30	24.27	8.59	7.87
EV/FCF Ratio	30.24	35.43	24.13	11.61	11.43	8.65
Debt / Equity Ratio	0.46	0.50	0.49	0.70	0.73	0.48
Debt / EBITDA Ratio	3.75	4.10	1.53	2.79	1.38	0.82
Debt / FCF Ratio	5.41	5.94	3.84	2.26	2.09	0.99
Quick Ratio	0.95	0.92	2.15	1.34	1.32	1.43
Current Ratio	2.10	2.00	2.99	1.83	1.84	1.72
Asset Turnover	0.36	0.38	0.42	0.46	0.53	0.54
Return on Equity (ROE)	7.90%	8.10%	24.70%	14.60%	35.30%	43.50%
Return on Assets (ROA)	4.40%	4.40%	12.40%	6.50%	15.80%	21.90%
Return on Capital (ROIC)	5.27%	5.25%	14.86%	9.13%	21.83%	29.86%
Earnings Yield	3.54%	3.10%	7.64%	4.42%	10.62%	11.00%
FCF Yield	3.90%	3.30%	4.32%	9.54%	9.96%	11.97%
Buyback Yield / Dilution	-0.48%	0.27%	2.41%	7.25%	13.93%	8.72%
Total Shareholder Return	-0.48%	0.27%	2.41%	7.25%	13.93%	8.72%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).